• 제목/요약/키워드: Fetal Dose

검색결과 128건 처리시간 0.027초

몬테카를로 방법을 이용한 임신한 여성 핵의학 종사자의 모체 장기 및 태아선량 평가 (Assessment of Maternal Organs and Fetal Doses in Pregnant Female Nuclear Medicine Practitioners Using the Monte Carlo Method)

  • 조용인
    • 대한방사선기술학회지:방사선기술과학
    • /
    • 제45권4호
    • /
    • pp.331-339
    • /
    • 2022
  • The purpose of this study was to evaluate maternal organ and fetal doses by week of pregnancy for pregnant women nuclear medicine practitioners in the nuclear medicine field. In addition, we intend to present basic data for the management of exposure doses of female nuclear medicine practitioners. In this study, phantoms of childbearing women, 3, 6, 9 months pregnant women were simulated using MCNPX(Monte Carlo N-Particle Extended) among the Monte Carlo methods. First, volume source was constructed based on 10 cm of the anterior part of the lower abdomen of the phantom, and the organ and fetal doses were evaluated for each week of the pregnant woman according to the type of radioactive isotope. Second, the organ and fetal dose of pregnant women were evaluated by increasing the distance between the source and the abdominal surface by 50 and 100 cm. As a result, 18F sources showed high organ and fetal doses in pregnant women 0 to 3 months, and the dose distribution gradually decreased in 6 to 9 months pregnant women. The distribution of organ and fetal doses for 99mTc and 123I sources showed the same tendency as that of 18F, and the overall absorbed dose distribution was relatively lower than that of 18F. Through this study, it is considered that workers in the early stages of pregnancy within 3 months will need appropriate management to minimize occupational exposure dose.

Fetal dose from Head and Neck Tomotherapy Versus 3D Conformal Radiotherapy

  • Park, So Hyun;Choi, Won Hoon;Choi, Jinhyun
    • Journal of Radiation Protection and Research
    • /
    • 제44권4호
    • /
    • pp.156-160
    • /
    • 2019
  • Background: To compare the dose of radiation received by the fetus in a pregnant patient irradiated for head and neck cancer using helical tomotherapy and three-dimensional conformal radiation therapy (3DCRT). Materials and Methods: The patient was modeled with a humanoid phantom to mimic a gestation of 26 weeks. Radiotherapy with a total dose of 2 Gy was delivered with both tomotherapy (2.5 and 5.0 cm jaw size) and 3DCRT. The position of the fetus was predicted to be 45 cm from the field edge at the time of treatment. The delivered dose was measured according to the distance from the field edge and the fetus. Results and Discussion: The accumulated dose to the fetus was 1.6 cGy by 3DCRT and 2 and 2.3 cGy by the 2.5 and 5 cm jaw tomotherapy plans. For tomotherapy, the fetal dose with the 2.5 cm jaw was lower than that with the 5 cm jaw, although the radiation leakage was greater for 2.5 cm jaw plan due to the 1.5 fold longer beam-on time. At the uterine fundus, tomotherapy with a 5 cm jaw delivered the highest dose of 2.4 cGy. When the fetus moves up to 35 cm at the 29th week of gestation, the resultant fetal doses for 3DCRT and tomotherapy with 2.5 and 5 cm jaws were estimated as 2.1, 2.7, and 3.9 cGy, respectively. Conclusion: For tomotherapy, scattering radiation was more important due to the high monitor unit values. Therefore, selecting a smaller jaw size for tomotherapy may reduce the fetal dose. however, evaluation of risk should be individually performed for each patient.

복부 진단 X선 검사 시 태아 및 임산부의 선량 평가 (Dose Assessment during Pregnancy in Abdominal X-ray Examinations)

  • 우리원;조용인;김정훈
    • 한국방사선학회논문지
    • /
    • 제14권3호
    • /
    • pp.261-270
    • /
    • 2020
  • 진단 방사선 검사에서 임산부와 태아에 대한 선량 평가는 현실적으로 어려우며, 관련된 연구 자료 또한 부족한 실정이다. 이에 본 연구에서는 모의실험을 통해 복부 X선 검사 시 임산부에 대한 선량과 태아선량을 분석하고자 하였다. 본 연구에서는 ICRP 89에서 제시하는 자료를 토대로 기존의 임산부 팬텀을 재구성한 팬텀을 제작 하였으며, 이를 이용하여 임신 주 수에 따른 임산부의 장기선량 및 태아선량에 대한 평가와 기존 팬텀과 재구성된 팬텀의 선량 차이를 분석하였다. 그 결과 복부 X선 검사 시, 입사되는 선원방향에 가까운 장기일수록 높은 선량을 나타내는 경향을 보였다. 또한 후전방향 촬영 시, 전후방향 촬영보다 태아 선량이 약 65%이상 감소하는 것을 확인할 수 있었다.

흉부 후전방향 검사 시 임산부의 선량 평가 (Dose Assessment during Pregnancy in Chest PA Examination)

  • 우리원;조용인;김정훈
    • 한국방사선학회논문지
    • /
    • 제14권5호
    • /
    • pp.661-668
    • /
    • 2020
  • 임산부의 사망 원인으로 색전증이 발생하며, 이를 검사하기 위해 흉부 방사선 검사를 수행한다. 이외에도 분만 전 응급 수술을 대비하거나 기본 진단 등의 목적으로 검사가 수행된다. 실제 측정을 통해 태아 선량을 평가하는 것은 윤리적 문제가 따르기 때문에, 사전연구로 제작된 팬텀을 통해 흉부 후전방향 검사에서 임신 주 수에 따른 임산부의 장기선량 및 태아선량을 평가하였다. 모의실험 결과 임신 주 수에 따라 태아선량은 감소하였으며, 약 0.1 mGy의 선량을 나타내었다. 차폐를 사용할 때, 차폐 물성으로 밀도가 높고, 두께가 두꺼울수록 차폐 효과가 우수하며 차폐 물성과 두께에 따라 40 ~ 98% 선량이 감소하였다. 또한 완전차폐보다 단면차폐로도 태아선량을 감소하는 것을 확인할 수 있었다. 이후 다양한 차폐물성과 방법 등을 통해 태아선량을 줄일 수 있는 연구가 필요한 것으로 사료된다.

염화메틸수은에 폭로된 임신 흰쥐에서 모체와 태자의 장기에 축적된 수은농도의 비교 (Comparison of the Mercury Levels Between Maternal and Fetal Organs in Pregnant Fisher-344 Rats)

  • 이진헌
    • 한국환경보건학회지
    • /
    • 제20권3호
    • /
    • pp.39-48
    • /
    • 1994
  • The purpose of this study was to determine the mercury accumulated at maternal and fetal organs, and compare its levels between maternal and fetal organs on day 20 of gestation, in pregnant Fisher-344 rats which given orally methylmercuric chloride on day 7 of gestation. Pregnant rats were divided four groups by dose: control group, and methylmercuric chloride treatment groups of 10, 20 and 30 mg/kg, respectively. The results obtained are as follows: I The mercury concentrations in maternal organs were the highest in kidney, and followed by blood, spleen, liver and brain. 2. The slopes of regression equation among mercury dose levels in maternal organs were as follows: Kidney 3.62 (r$^2$=0.943), Blood 2.75 (r$^2$=0.941), Spleen 2.49 (r$^2$=0.990), Liver 1.13 (r$^2$= 0.949), Brain 0.33 (r$^2$=0.984). 3. The mercury concentrations in fetal organs and placenta were the highest in liver, and followed by kidney, placenta and brain. 4. The slopes of regression equation among mercury dose levels in fetal organs and placenta were as follows: Liver 1.79 (r$^2$= 0.968), Kidney 0.79 (r$^2$= 0.976), Placenta 0.68 (r$^2$= 0.920), Brain 0.52 (r$^2$= 0.978), All Body 0.58 (r$^2$= 0.941). 5. As to the mercury levels in kidney, dams were 4.8~14.9 times higher than fetus. But as to the mercury levels in liver and brain, fetus were 1.6~2.5 and 1.5~1.9 times higher than dams. In conclusion, the mercury which exposured to pregnant rats can easily pass through the placenta and accumulated in fetus, especially higher in fetal liver and brain.

  • PDF

임산부의 방사선치료 시 태아선량 평가 (Estimation of Fetal Dose during Radiation Therapy of Pregnant Patient)

  • 정치훈;김찬용;김보겸;서석진;유숙현;박흥득
    • 대한방사선치료학회지
    • /
    • 제19권1호
    • /
    • pp.35-41
    • /
    • 2007
  • 목 적: 임산부의 방사선치료시 태아에 조사되는 선량을 알아보고, 임상에 적용가능한 간단한 차폐방법을 적용하여 태아선량이 감소되는 정도를 평가하고자 한다. 대상 및 방법: 본원에 내원한 임신 24주째인 뇌전이 환자를 대상으로 전뇌 방사선치료를 시행하는 동안 태아에 조사되는 선량을 인체 팬톰(Anderson Rando Phantom, Alderson Research Laboratories Inc., USA)을 사용하여 평가하였다. 환자에 대한 치료처방은 일일선량 300 cGy, 10회, 총선량 3000 cGy, 그리고 치료조건은 에너지 6 MV, 조사야크기 $18{\times}22cm^2$이었다. 선량평가는 환자 치료조건과 동일한 상태로 조사야 하단에서 각각 30, 40, 50, 60 cm에서 전리함((TN30013, 0.6 cc Farmer type chamber, PTW Unidos, Germany)을 사용하여 측정하였고, 다음은 환자치료조건과 동일하지만 본원에서 고안한 추가 차폐방법(shielding wall, neck supporter, Pb sheets, acrylic bridge)을 이용하여 태아를 차폐한 다음 위의 측정점과 동일한 위치에서 측정하여 그 차폐효과를 비교 평가 하였다. 또한 추가 차폐한 상태에서 열형광선량계(4000, Harshaw, Solon Technologies Inc., USA)를 사용하여 30, 40, 50, 60, 70 cm 지점에서 측정하여 전리함 측정값과 비교 분석하였다. 결 과: 전리함을 이용하여 측정한 결과 환자가 총선량 3,000 cGy를 받는 동안 태아에 조사될 수 있는 선량은, 추가 차폐가 없는 경우 조사야 하단 30, 40, 50, 60 cm에서 각각 3.20, 3.21, 1.44, 0.90 cGy, 추가 차폐가 있는 경우 0.88, 0.60, 0.35, 0.25 cGy로 추가 차폐를 하였을 경우 하지 않았을 경우보다 약 $70{\sim}80%$의 차폐효과를 얻을 수 있었다. 그리고 열형광선량계 측정결과는 1.8, 1.2, 0.8, 1.2, 0.8 (70 cm) cGy로 나타났다. 이로서 태아가 전 치료 과정중 받을 수 있는 총선량은 1 cGy 이하로 측정되었다. 결 론: 임산부의 방사선치료가 필수적으로 요구될 경우 고려되어야 할 가장 중요한 인자는 태아선량의 최소화가 될 것이다. 방사선장애의 역치선량이 $10{\sim}20cGy$인 것을 감안하면 상기 방법에 의한 임산부의 방사선치료는 이러한 목적에 부합될 뿐만 아니라 사용방법 또한 비교적 용이하다고 생각된다.

  • PDF

Effects of Epidermal Growth Factor and Insulin-like Growth Factor-I on Placental Amino Acids Transport Activities in Rats

  • Ono, Kenichiro
    • 한국수정란이식학회:학술대회논문집
    • /
    • 한국수정란이식학회 2002년도 국제심포지엄
    • /
    • pp.34-36
    • /
    • 2002
  • Epidermal growth factor (EGF) and insulin-like growth factor-I (IGF-I) have been shown to stimulate proliferation and differentiation of various somatic cells, including placental trophoblasts and also to enhance fetal growth and development when maternally administered. Since an increase of the expression of placental EGF and IGF-I receptors in rat, mouse, and human with the gestation advanced, both EGF and IGF-I were considered to play pivotal roles on fetal growth by regulating some function of placental cells. Amino acids are crucial importance for both maternal and fetal requirements of energy source and essential constituent of fetal mass during pregnancy. Impaired fetal and placental uptake of amino acids has been observed in several models of growth retardation in the rat. Amino acid is concentrated in the fetal side through active transport by amino acid transporters and is one of the important metabolic fuels for the fatal growth. Therefore, at first plasma amino acid concentrations in mothers and fetuses were measured as an index of uphill transport across the placenta associated with EGF and IGF-1. The EGF administration at the concentration of 0, 0.1, or 0.2 $\mu\textrm{g}$/g to pregnant rats from day 18 to 21 of gestation apparently increased fetal/maternal ratio of serum proline concentration and also fatal growth in EGF dose-dependent manner. When IGF-I in doses of 0, 1, 2, and 4 $\mu\textrm{g}$/g were administrated, the ratio of leucine, isoleucine, tryptophan, phenylalanine, tyrosine and also fetal growth significantly increased with a dose-dependent manner. These results suggested that EGF and IGF-I enhanced fatal growth by, as one of its possible mechanisms, promoting placental activity to transfer some amino acid supplies from the mother to the fetus in late pregnancy.

  • PDF

X-線 照射가 래트 태아의 발육에 미치는 영향 (Effect of X-irradiation on Fetal Development During Pregnancy in the Rats)

  • 오홍근;김용준
    • 한국임상수의학회지
    • /
    • 제18권2호
    • /
    • pp.146-151
    • /
    • 2001
  • This study was carried out to find if the X-irradiation being used for clinical diagnosis during pregnancy would affect fetal development and cause fetal malformation in rats or not. To determine the dose and irradiation frequency of X-irradiation and gestation period by which fetal development would be affected when irradiated during pregnancy, seventy-two Sprague Dawley female rats (8 weeks old) were used for the experiment and grouped into three according to different gestation period of 5-8 days, and 6-12 days of gestation. Experimental rats were irradiated on the daily irradiation conditions of 40, 60, 80 kvp(kilo volt peak), 150 mA(milliampere), 0.25 sec and 4 times/day for both 5-8 days and 10-13 days of gestation, and 100 kvp, 100 mA, 2 min. and 4 times/day for 6-12 days of gestation. Rats were put in a small dark box when irradiated, which animals were sacrificed on the 20th day of gestation and mean litter size, fetal body weight, fetal crown-rump length(CRL) were investigated along with pathological findings. 1. Litter size were significantly decreased in the rats which were irradiated by both 60 and 80 kvp during 5 to 8 days of gestation and by 100 kvp during 6-12 days of gestation compared to those from the control rats(p<0.05) 2. Fetal body weight was significantly decreased in the fetus from the rats which were irradiated by both 60-80 kvp during 5-8 days of gestation and by 100 kvp during 6-12 days of gestation compared to those from the control rats(p<0.05). 3. There was no significant difference of fetal crown-rump length between all the experimental rats and the controls. 4. Fetal absorption, fetal death, and fetal malformation were not observed in the fetus form the rats irradiated by 40-80 kvp during 5-8 and 10-13 days of gestation, however, the pathological findings were found in those from the rats irradiated by 100 kvp during 6-12 days of gestation. 5. The harmful effect of x-irradiation on fetal development was estimated to occur when irradiated during 5-8 days of gestation. These results indicated that even X-irradiation for clinical diagnosis could affect fetal development in the early embryonic stage and when the fetus were exposed to frequent and prolonged x-irradiation with over dose.

  • PDF

Sprague-Dawley 랫드에서 2-Bromopropane의 배자치사 및 최기형성 효과 (Embryo lethality and teratogenicity of 2-Bromopropane in the Sprague-Dawley rat)

  • 김종춘;오기석;신동호;김성호;김현영;윤효인;강성철;허정두;정문구
    • 대한수의학회지
    • /
    • 제43권4호
    • /
    • pp.657-666
    • /
    • 2003
  • The present study was undertaken to evaluate the potential adverse effects of 2-BP on pregnant dams and embryo-fetal development after maternal exposure during the gestational days (GD) 6 through 19 in Sprague-Dawley rats. The test chemical was administered subcutaneously to pregnant rats at dose levels of 0, 375, 750 and 1250 mg/kg/day. During the test period, clinical signs, mortality, body weights and food consumption were examined. All dams were subjected to caesarean section on GD 20 and their fetuses were examined for external, visceral and skeletal abnormalities. At above 750 mg/kg, toxic effects including signs of toxicity, suppressed body weight, decreased gravid uterine weight and reduced food intake were observed in pregnant dams. An increase in the fetal deaths, a decrease in the litter size, a reduction in the fetal body weight and an increase in the incidence of fetal morphological alterations were also found. There were no adverse effects on either pregnant dams or embryo-fetal development at a dose level of 375 mg/kg. These results suggest that a 14-day subcutaneous dose of 2-BP is embryolethal and teratogenic at above 750 mg/kg/day in pregnant rats. In the present experimental condition, the no-observed-adverse-effect level of 2-BP is considered to be 375 mg/kg/day for dams and embryo-fetuses, respectively.

임신 랫트의 페놀 노출에 따른 태자의 발육 지연효과 (Fetal growth retardation induced by maternal exposure to phenol in the rat)

  • 정문구
    • 대한수의학회지
    • /
    • 제34권3호
    • /
    • pp.601-607
    • /
    • 1994
  • This study was carried out to investigate the potential of phenol to induce embryotoxicity in the Sprague-Dawley rat. Seventy mated rats were distributed among three treated troups, a vehicle control group and a negative control group. Phenol was at dose levels of 20, 60 and 180mg/kg/day adminsistered by gavage to pregnant rats three times per day from days 7 to 12 of gestation. All dams were subjected to the caesarean section on day 20 of gestation. At 120mg/kg, dams exhibited decreased locomotivity. In addition, both weight reduction and retarded ossification of fetuses were observed. There were no signs of maternal toxicity or embryotoxicity at 20 and 60mg/kg. The results show that phenol induces fetal growth retardation at maternally subtoxic dose in rats.

  • PDF